Immediate Impact
2 from Science/Nature 64 standout
Citing Papers
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Works of Karan P. Singh being referenced
Metabolites enhance innate resistance to human Mycobacterium tuberculosis infection
2022
A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Karan P. Singh | 393 | 448 | 483 | 891 | 501 | 178 | 3.8k | |
| Jeffrey M. Albert | 487 | 480 | 712 | 882 | 649 | 152 | 4.6k | |
| Joan F. Hilton | 847 | 459 | 330 | 811 | 774 | 127 | 6.1k | |
| Youping Li | 241 | 189 | 389 | 1001 | 587 | 251 | 6.5k | |
| Sarah Wordsworth | 595 | 516 | 347 | 487 | 388 | 146 | 5.7k | |
| Andrew S. Wilton | 861 | 352 | 740 | 411 | 479 | 112 | 5.1k | |
| Prakash C. Gupta | 739 | 743 | 777 | 801 | 874 | 180 | 10.0k | |
| Thomas Fanshawe | 396 | 676 | 362 | 653 | 416 | 145 | 4.5k | |
| Anthony Staines | 253 | 522 | 743 | 347 | 613 | 204 | 5.4k | |
| Kamal R Mahtani | 192 | 816 | 292 | 909 | 506 | 131 | 4.8k | |
| Mark Clements | 1077 | 751 | 601 | 601 | 718 | 141 | 4.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...